See, Blind Mice: Consortium’s Drugs Restore Sight
A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in preclinicial tests restored sight in blind mice. The team’s approach...
Protein Design’s AI Revolution: Inside David Baker’s “Communal Brain”
“I have this idea of a communal brain.” David Baker, PhD, told me as I sat in his office at the University of Washington (UW) surrounded by colorful and complex figurines of protein structures....
Analytical Challenges for Antibody-Drug Conjugate (ADC) Manufacturing
Read NowAntibody-drug conjugates (ADCs) offer a compelling promise: delivering a cytotoxic payload directly to a tumor cell while sparing the rest of the body from harm. Composed of a tumor-targeting antibody, a cytotoxic agent,...
Ag Genomics Begins to Bear Fruit
Agrigenomics is, to use an analogy, spring looking toward summer. Wielding modern genomics tools fine-tuned to agriculture, along with AI-driven insights from field technologies and satellites in low Earth orbit, traditional agriculture is transitioning...
Top 10 Best-Selling Drugs 2026
Thanks to booming sales of blockbuster obesity and diabetes treatments, the amount that Americans spent on prescription drugs this year is on track to surpass $1 trillion, according to a report released in April...
Virtual Cells Go Multiscale to Predict Complex Biology
Virtual cell models that enable the prediction of cell behavior across scales and biological contexts are rapidly emerging at the forefront of drug discovery.
Tom Sercu, PhD, vice president of AI and engineering at Biohub,...
Advanced Cell Sorting Balances Precision, Scale, and Simplicity
Within complex biological samples, the most important cells are often the hardest to find. Identifying, characterizing, and isolating rare or functionally-distinct populations has become central to modern cell biology, translational research, and cell therapy...
Fujifilm Selected with Six Others in FDA PreCheck Pilot Manufacturing Program
Fujifilm Biotechnologies reports that its commercial-scale cell culture manufacturing facility in Holly Springs, NC, has been selected as one of only seven participants in the FDA’s PreCheck Pilot Program. The program, which also includes Amneal Pharmaceutical,...
Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare disease portfolio beyond its anchor indication of cystic fibrosis (CF),...
Pharma Races to Scale AI as Billions Flow into Drug Discovery
“I’ve always believed the No.1 application of AI should be to improve human health.”
–Demis Hassabis, PhD, CEO of Google DeepMind and Isomorphic Labs, 2024 Nobel Laureate in Chemistry
The infrastructure moment for AI-driven drug discovery...
